BlackRock Fund Advisors’s Harvard Bioscience HBIO Stock Holding History

BlackRock Fund Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$319K	Buy	10,458 +723	+7%	+$18.4K	﹤0.01%	3320
2016 Q3	$265K	Buy	9,735 +1,765	+22%	+$49K	﹤0.01%	3362
2016 Q2	$228K	Sell	7,970 -79,104	-91%	-$2.52M	﹤0.01%	3406
2016 Q1	$2.63M	Buy	87,074 +38	+0%	+$1.08K	﹤0.01%	2996
2015 Q4	$3.02M	Buy	87,036 +2,780	+3%	+$95.1K	﹤0.01%	3039
2015 Q3	$3.19M	Sell	84,256 -1,004	-1%	-$46.7K	﹤0.01%	2997
2015 Q2	$4.86M	Buy	85,260 +77,602	+1,013%	+$4.42M	﹤0.01%	2938
2015 Q1	$446K	Sell	7,658 -518	-6%	-$27.8K	﹤0.01%	3287
2014 Q4	$464K	Buy	8,176 +583	+8%	+$27.8K	﹤0.01%	3280
2014 Q3	$311K	Sell	7,593 -551	-7%	-$25.3K	﹤0.01%	3316
2014 Q2	$371K	Sell	8,144 -65,213	-89%	-$2.74M	﹤0.01%	3273
2014 Q1	$3.48M	Buy	73,357 +2,976	+4%	+$135K	﹤0.01%	3008
2013 Q4	$3.31M	Sell	70,381 -27,994	-28%	-$1.22M	﹤0.01%	3028
2013 Q3	$3.92M	Buy	98,375 +9,393	+11%	+$369K	﹤0.01%	2957
2013 Q2	$3.17M	Buy	+88,982	New	+$3.41M	﹤0.01%	2958

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPC

Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BlackRock Fund Advisors's HBIO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Harvard Bioscience (HBIO) stake by 7.4% in Q4 2016, buying an estimated $18.4K and bringing the position to 10,458 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

BlackRock Fund Advisors first reported a position in HBIO in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.86M in Q2 2015. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2016.

BlackRock Fund Advisors held 10,458 shares of Harvard Bioscience worth $319K as of Q4 2016.
BlackRock Fund Advisors bought 723 Harvard Bioscience shares in Q4 2016, an estimated $18.4K.
Harvard Bioscience made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3320 holding.
BlackRock Fund Advisors first reported a position in Harvard Bioscience in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Harvard Bioscience position peaked at $4.86M in Q2 2015.
68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.